R. P. Symonds

发表

Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.

Petra Seibold, Frederik Wenz, Alison M Dunning, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients.

J. Chang-Claude, P. Seibold, C. West, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity

J. Chang-Claude, F. Wenz, C. West, 2019, Clinical and translational radiation oncology.

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.

J. Chang-Claude, T. Vercauteren, A. Dunning, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Refining the evidence for GSTA1 and eNOS genetic effects on risk of radiotherapy‐induced telangiectasia

G. Giotopoulos, C. Talbot, I. Peat, 2008, International journal of cancer.

Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies.

A. Dunning, P. Pharoah, C. Coles, 2012, International journal of radiation oncology, biology, physics.

Variation in telangiectasia predisposing genes is associated with overall radiation toxicity.

K. Cheung, S. Chan, J. Barwell, 2012, International journal of radiation oncology, biology, physics.

Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort

J. Chang-Claude, D. Soria, P. Seibold, 2022, Advances in radiation oncology.

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, EBioMedicine.

Are depressive symptoms more common among British South Asian patients compared with British White patients with cancer? A cross-sectional survey

A. Mitchell, R. P. Symonds, K. Lord, 2013, BMJ Open.

Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo

S. McKeown, V. McKelvey-Martin, J. Mellon, 2014, International journal of cancer.

A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy

Daniele Soria, Thierry J. Chaussalet, Barry S. Rosenstein, 2021, Comput. Biol. Medicine.

External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort

J. Chang-Claude, A. Dunning, P. Seibold, 2020, Frontiers in Oncology.

XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.

J. Chang-Claude, J. Debus, A. Dunning, 2015, International journal of radiation oncology, biology, physics.

Association between single nucleotide polymorphisms in the DNA repair gene LIG3 and acute adverse skin reactions following radiotherapy.

K. Cheung, S. Chan, J. Barwell, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

ATM rs1801516 SNP and toxicity after radiotherapy

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

Improving and predicting radiosensitivity in muscle invasive bladder cancer.

J. Mellon, R. Kockelbergh, A. Colquhoun, 2003, The Journal of urology.

Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial

C. West, C. Dive, Susana Banerjee, 2015, The Lancet. Oncology.

Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients.

P. Seibold, D. Ruysscher, B. Rosenstein, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

The Patient Perspective on Radiogenomics Testing for Breast Radiation Toxicity

S. Shokuhi, C. Talbot, R. Symonds, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).